Study identifier:D3250R00101
ClinicalTrials.gov identifier:NCT05271526
EudraCT identifier:N/A
CTIS identifier:N/A
A multicenter, single arm, non-interventional, observational, prospective study to assess demographic characteristics, burden of disease and short-term patient reported outcomes on symptom relief in severe eosinophilic asthma patients aged older than 18 qualifying for treatment with benralizumab in Russia
Severe Eosinophilic Asthma
N/A
No
-
All
3
Observational
n/a - n/a
Allocation: N/A
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verified 01 Dec 2023 by AstraZeneca
AstraZeneca
-
No locations available
Arms | Assigned Interventions |
---|